Kinapse

Kinapse is a leading global provider of advisory, capability building and operational services to the life sciences industries. The company provides services to the world’s leading life sciences organisations, their customers, suppliers and regulators across a range of specialist areas, including quality and compliance, regulatory and medical affairs, pharmacovigilance and clinical trial disclosure.
Hg partnered with Kinapse in 2016 to support the business in achieving its goal of becoming a market-leading advisory and outsourcing business in a rapidly growing segment of the pharma value chain.
In August 2018, Kinapse was acquired by Syneos Health, Inc, a leading biopharmaceutical solutions organisation.
Latest from the world of Kinapse
Navigate what’s next: a new brand system for Hg
AI needs new pricing. Customers need a reason to accept it.
New AI transformation company raises funding to advance AI adoption in Europe
The Value Creation Team is now Hg Catalyst
3E secures majority investment from Hg
From customer to CEO, Lucanet's Elias Apel on transforming a business through the eyes of the user
Lucanet is building trustworthy AI into the office of the CFO
What German software leaders are telling us about AI
KKR to acquire Gen II Fund Services for more than $5 billion from Hg and General Atlantic
More from Healthcare IT
View All















